EURACTIV PR

An easy way of publishing your relevant EU press releases.

Medicines for Europe

Press Releases of this organisation

TITLEsort descending ORGANISATION DATE TOPIC
European Commission launches: “What I need to know about Biosimilar Medicines - Information for patients”, in 23 EU languages Medicines for Europe 29 Nov 2017 Health & Consumers
European Health Union – first step to greater EU solidarity in health crisis situations Medicines for Europe 11 Nov 2020 Health & Consumers
European Organisation for Specialised Nurses (ESNO) launches switch management guide between similar biological medicines - a guide for nurses Medicines for Europe 26 Jun 2018 Health & Consumers
European patients need improved access to biosimilar medicines Medicines for Europe 22 Apr 2021 Health & Consumers
Europe’s life science industry urges the UK and EU27 to safeguard patients’ access to medicines with a clear transition period and a future cooperation agreement after Brexit Medicines for Europe 28 Nov 2017 Health & Consumers, UK in Europe
Failure to launch: white paper explores the role of inappropriate use of IP in blocking access to generic and biosimilar medicines Medicines for Europe 05 Nov 2020 Health & Consumers
Fulfilling the Biosimilar Promise: Report Highlights Key Principles in Support of a Sustainable Market Medicines for Europe 19 Sep 2016 Health & Consumers
Generic & biosimilar medicines pivotal for safe, effective and affordable access to medicines in Europe Medicines for Europe 28 Nov 2019 Health & Consumers
Health at a Glance Report highlights public value of generic, biosimilar and value added medicines Medicines for Europe 26 Nov 2018 Health & Consumers
IGBA congratulates the Australian Government for maintaining their Biologics Naming Convention and for strengthening pharmacovigilance Medicines for Europe 29 Jan 2018 Health & Consumers
IGBA launches a Biosimilar Medicines Information Campaign Medicines for Europe 01 Feb 2018 Health & Consumers
Immediately calls on new President of EU Commission to prioritise Healthcare Medicines for Europe 25 Sep 2019 Health & Consumers, InfoSociety
IQVIA Institute Scorecards show biosimilar medicines offer win for patients, policymakers and healthcare systems across Europe Medicines for Europe 30 Jun 2020 Health & Consumers
Latest Data Shows the Need to Promote Biosimilar and Value Added Medicines for Better Health Medicines for Europe 16 Jun 2017 Health & Consumers
Medicines for Europe announces new President, launches Access to Medicines campaign Medicines for Europe 10 Oct 2017 Health & Consumers
Medicines for Europe calls for greater cooperation on value added medicines to improve patient-centric innovation Medicines for Europe 22 Nov 2017 Health & Consumers
Medicines for Europe can contribute much more to improve healthcare sustainability than described in the OECD “Health at a Glance 2016” report Medicines for Europe 24 Nov 2016 Health & Consumers
Medicines for Europe members publish disclosure of Transfers of Value to the healthcare community Medicines for Europe 22 Jun 2018 Health & Consumers
Medicines for Europe statement on COVID-19 (‘coronavirus’) Medicines for Europe 13 Mar 2020 Health & Consumers
Medicines for Europe to join the ISPOR Issue Panel on value added medicines Medicines for Europe 05 Oct 2017 Health & Consumers
Medicines for Europe welcomes Competitiveness Council discussion to stop delocalisation of medicine manufacturing. It is time to effectively position Europe as a global hub for the production of medicines. Medicines for Europe 30 Nov 2018 Health & Consumers
Medicines for Europe, APOGEN and Fresenius Kabi hold Open Industry Day in Portugal Medicines for Europe 14 Nov 2019 Health & Consumers
New report assesses progress on biosimilar medicine policies across Europe Medicines for Europe 30 Mar 2021 Health & Consumers
New report reveals need for pricing and reimbursement and procurement reforms to ensure patient access and healthcare sustainability Medicines for Europe 01 Mar 2021 Health & Consumers
New safeguards for patient safety as Falsified Medicines Directive comes into force Medicines for Europe 11 Feb 2019 Health & Consumers
No further excuse to delay digital regulatory infrastructure for medicines after COVID-19 pandemic Medicines for Europe 19 Feb 2021 Health & Consumers
Now or never: pragmatism & ambition needed in EU pharma strategy to deliver on Europe’s medicines manufacturing Medicines for Europe 07 Oct 2020 Health & Consumers
Off patent medicines essential for a fairer, healthier, and sustainable Europe says President Christoph Stoller Medicines for Europe 30 Apr 2021 Health & Consumers
Oncology, the new era for biosimilar medicines Medicines for Europe 08 Sep 2017 Health & Consumers
Parliament’s Health Committee (ENVI) introduces constructive amendments to SPC Manufacturing waiver vote in its official opinion to the Parliament’s Legal Committee (JURI). Medicines for Europe 28 Nov 2018 Health & Consumers

Pages